SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phaseKomal Srivastava, Temima Yellin, Giulio Kleiner et al.|Immunity|2024Cited by 134
Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patientsAdolfo Aleman, Samir Parekh, Oliver Van Oekelen et al.|Cancer Cell|2022Cited by 38
Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infectionDisha Bhavsar, Yuexing Chen, Gagandeep Singh et al.|mBio|2023Cited by 20
The post-COVID-19 population has a high prevalence of cross-reactive antibodies to spikes from all <i>Orthocoronavirinae</i> generaGagandeep Singh, Temima Yellin, Anass Abbad et al.|mBio|2023Cited by 15